CCR6 and colorectal carcinoma: As the suggested key mechanism underlying the enhancing influence of CCL20/CCR6 on CRC progression and chemoresistance, CCL20 is able to trigger the intratumoral accumulation of CCR6+ Treg cells and, thereby, to counteract the antitumor immune response [27,59].